Splenectomy after allogeneic haematopoietic stem cell transplantation in patients with primary myelofibrosis: Correspondence

British Journal of Haematology

Volumn 150, Issue 6, 2010, Pages 721-724

  Robin, Marie ^a   Espérou, Hélène ^a   De Latour, Régis Peffault ^a   Petropoulou, Anna D ^a   Xhaard, Aliénor ^a   Ribaud, Patricia ^a   Socié, Gérard ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

allogeneic haematopoietic stem transplantation; myelofibrosis; splenomegaly

Indexed keywords

CYCLOSPORIN; FOSCARNET SODIUM; GANCICLOVIR; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TECHNETIUM 99M; THYMOCYTE ANTIBODY;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; LEUKOPENIA; MALE; MYELOFIBROSIS; PANCYTOPENIA; PRIORITY JOURNAL; SPLENECTOMY; SPLENOMEGALY; THROMBOCYTE COUNT;

FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PANCYTOPENIA; PRIMARY MYELOFIBROSIS; SPLENECTOMY; SPLENOMEGALY;

EID: 77956315091     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08276.x     Document Type: Letter

References (7)

1. Bacigalupo, A., Soraru, M., Dominietto, A., Pozzi, S., Geroldi, S., Van Lint, M.T., Ibatici, A., Raiola, A.M., Frassoni, F., De Stefano, F., Verdiani, S., Casarino, L. Barosi, G. (2010) Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type. Bone Marrow Transplantation, 45, 458 463.
2. Guardiola, P., Anderson, J.E., Bandini, G., Cervantes, F., Runde, V., Arcese, W., Bacigalupo, A., Przepiorka, D., O'Donnell, M.R., Polchi, P., Buzyn, A., Sutton, L., Cazals-Hatem, D., Sale, G., de Witte, T., Deeg, H.J. Gluckman, E. (1999) Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Societe Francaise de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study. Blood, 93, 2831 2838.
3. Kerbauy, D.M., Gooley, T.A., Sale, G.E., Flowers, M.E., Doney, K.C., Georges, G.E., Greene, J.E., Linenberger, M., Petersdorf, E., Sandmaier, B.M., Scott, B.L., Sorror, M., Stirewalt, D.L., Stewart, F.M., Witherspoon, R.P., Storb, R., Appelbaum, F.R. Deeg, H.J. (2007) Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia. Biology of Blood and Marrow Transplantation, 13, 355 365.
4. Kroger, N., Holler, E., Kobbe, G., Bornhauser, M., Schwerdtfeger, R., Baurmann, H., Nagler, A., Bethge, W., Stelljes, M., Uharek, L., Wandt, H., Burchert, A., Corradini, P., Schubert, J., Kaufmann, M., Dreger, P., Wulf, G.G., Einsele, H., Zabelina, T., Kvasnicka, H.M., Thiele, J., Brand, R., Zander, A.R., Niederwieser, D. de Witte, T.M. (2009) Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Blood, 114, 5264 5270.
5. Lissandre, S., Bay, J., Cahn, J., Cacheux, V., Cabrespine, A., Guyotat, D., Cassinat, B., Peffault de Latour, R., Socié, G. Robin, M. (2008) Allogeneic hematopoietic stem cell transplantation (HSCT) as a curative therapy in primary and secondary myelofibrosis (MF): a 14-year period oligocentric French experience. Blood (Annual Meeting Abstracts), 112, 1756.
6. Mesa, R.A., Nagorney, D.S., Schwager, S., Allred, J. Tefferi, A. (2006) Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic. Cancer, 107, 361 370.
7. Tefferi, A., Thiele, J., Orazi, A., Kvasnicka, H.M., Barbui, T., Hanson, C.A., Barosi, G., Verstovsek, S., Birgegard, G., Mesa, R., Reilly, J.T., Gisslinger, H., Vannucchi, A.M., Cervantes, F., Finazzi, G., Hoffman, R., Gilliland, D.G., Bloomfield, C.D. Vardiman, J.W. (2007) Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood, 110, 1092 1097.